Covered recipient · General Payments record
ERIN M BAROWSKI
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2023
$5,380.94
- Reported across 297 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $662.34 | 34 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $144.70 | 8 |
| PFIZER INC. | $101.28 | 5 |
| UCB, Inc. | $89.44 | 5 |
| Amgen Inc. | $68.90 | 4 |
| Janssen Biotech, Inc. | $57.97 | 3 |
| Aurinia Pharma U.S., Inc. | $46.26 | 2 |
| Lilly USA, LLC | $40.42 | 2 |
| E.R. Squibb & Sons, L.L.C. | $28.70 | 1 |
| Horizon Pharma plc | $26.00 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $20.40 | 1 |
| Acerta Pharma LLC | $19.80 | 1 |
| Mallinckrodt Hospital Products Inc. | $18.47 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2023 20212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.27 | 01/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002813357 | CMS |
| ABBVIE INC. | $25.68 | 01/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002813385 | CMS |
| ABBVIE INC. | $20.33 | 02/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002813397 | CMS |
| ABBVIE INC. | $7.18 | 02/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002813409 | CMS |
| ABBVIE INC. | $27.95 | 03/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002813421 | CMS |
| ABBVIE INC. | $26.97 | 03/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002813431 | CMS |
| ABBVIE INC. | $16.54 | 03/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002813447 | CMS |
| ABBVIE INC. | $2.78 | 03/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002813457 | CMS |
| Amgen Inc. | $18.54 | 01/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020314555 | CMS |
| Amgen Inc. | $19.46 | 01/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020314565 | CMS |
| Amgen Inc. | $15.61 | 01/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020314571 | CMS |
| Amgen Inc. | $15.29 | 01/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020314559 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.80 | 03/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014144015 | CMS |
| Aurinia Pharma U.S., Inc. | $21.96 | 02/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1057755797 | CMS |
| Aurinia Pharma U.S., Inc. | $24.30 | 02/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1057755799 | CMS |
| E.R. Squibb & Sons, L.L.C. | $28.70 | 02/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014633463 | CMS |
| Horizon Therapeutics plc | $26.00 | 02/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987095485 | CMS |
| Janssen Biotech, Inc. | $16.19 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988115809 | CMS |
| Janssen Biotech, Inc. | $23.29 | 02/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988115816 | CMS |
| Janssen Biotech, Inc. | $18.49 | 03/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988115799 | CMS |
| Lilly USA, LLC | $19.70 | 01/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032938319 | CMS |
| Lilly USA, LLC | $20.72 | 03/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032839929 | CMS |
| Mallinckrodt Hospital Products Inc. | $18.47 | 01/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1042938449 | CMS |
| Novartis Pharmaceuticals Corporation | $20.40 | 01/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 991552889 | CMS |
| PFIZER INC. | $18.26 | 01/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049112455 | CMS |
| PFIZER INC. | $19.43 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049525905 | CMS |
| PFIZER INC. | $22.06 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049435895 | CMS |
| PFIZER INC. | $28.13 | 03/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049394281 | CMS |
| PFIZER INC. | $13.40 | 03/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049617309 | CMS |
| UCB, Inc. | $18.35 | 01/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1021809339 | CMS |
| UCB, Inc. | $17.49 | 02/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1021809333 | CMS |
| UCB, Inc. | $12.98 | 02/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1021809321 | CMS |
| UCB, Inc. | $16.57 | 03/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1021809327 | CMS |
| UCB, Inc. | $24.05 | 03/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1021809345 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.